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Abstract
Background: Coffee contains biologically-active substances that suppress carcinogenesis in vivo, and coffee
consumption has been associated with a lower risk of malignant melanoma. We studied the impact of total
coffee consumption and of different brewing methods on the incidence of malignant melanoma in a prospective
cohort of Norwegian women.
Methods: We had baseline information on total coffee consumption and consumption of filtered, instant, and boiled
coffee from self-administered questionnaires for 104,080 women in the Norwegian Women and Cancer (NOWAC)
Study. We also had follow-up information collected 6–8 years after baseline. Multiple imputation was used to deal
with missing data, and multivariable Cox regression models were used to calculate hazard ratios (HR) for malignant
melanoma by consumption category of total, filtered, instant, and boiled coffee.
Results: During 1.7 million person-years of follow-up, 762 cases of malignant melanoma were diagnosed. Compared
to light consumers of filtered coffee (≤1 cup/day), we found a statistically significant inverse association with
low-moderate consumption (>1–3 cups/day, HR = 0.80; 95 % confidence interval [CI] 0.66–0.98) and high-moderate
consumption of filtered coffee (>3–5 cups/day, HR = 0.77; 95 % CI 0.61–0.97) and melanoma risk (ptrend = 0.02). We did
not find a statistically significant association between total, instant, or boiled coffee consumption and the risk of
malignant melanoma in any of the consumption categories.
Conclusions: The data from the NOWAC Study indicate that a moderate intake of filtered coffee could reduce
the risk of malignant melanoma.
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Background
Malignant melanoma constitutes 1.6 % of cancer cases
diagnosed among women worldwide, with an esti-
mated 111,000 cases in 2012. The highest age-
adjusted rates are found in Australia/New Zealand
(30.5 per 100,000). Melanoma incidence rates in
Northern and Western Europe are 15.4 and 12.8 per
100,000, respectively [1]. In recent years, Norway has
seen a rise in the age-adjusted incidence rate of ma-
lignant melanoma: from 15.9 per 100,000 in 2004 to
21.8 per 100,000 in 2013. Malignant melanoma now
constitutes 6.3 % of cases and is the fourth most
common cancer among Norwegian women [2].
Coffee contains caffeine, as well as potentially anticar-
cinogenic components such as chlorogenic acid, kah-
weol, and cafestol [3, 4]. However, levels of these
components depend on brewing method [5, 6]. Pro-
spective studies on coffee consumption and malignant
melanoma have shown conflicting results, ranging from
no association [7] to a lower relative risk [8–10]. Recent
meta-analyses of observational studies reported inverse
associations, with pooled relative risks of melanoma
among regular coffee drinkers compared to controls of
0.75 (95 % confidence interval [CI] 0.63–0.89) [11, 12],
and 0.80 (95 % CI 0.69–0.93) [11, 12].* Correspondence: marko.lukic@uit.no1Department of Community Medicine, Faculty of Health Sciences, UiT - The
Arctic University of Norway, NO-9037 Tromsø, Norway
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Coffee consumption in the Norwegian population is
high [13]. Thus, in the present study we investigated the
association between total coffee consumption and con-
sumption of filtered, instant, and boiled coffee on the in-




The Norwegian Women and Cancer (NOWAC) Study is
a nationally representative prospective cohort initiated
in 1991. Women aged 30–70 years were randomly se-
lected from the Central Population Register and mailed
an invitation to participate in the study along with a
self-administered questionnaire [14], which collected in-
formation on lifestyle, diet, and health status. More than
172,000 women returned the questionnaires (overall re-
sponse rate: 52.7 %) and written informed consent was
obtained from all study participants. The NOWAC
Study was approved by the Regional Committee for
Medical Research Ethics and the Norwegian Data
Inspectorate.
We used baseline data collected during three waves of
recruitment into the NOWAC Study (1991–1992, 1996–
1997, and 2003–2004). Our initial study cohort consisted
of the 110,548 women who completed a version of the
NOWAC questionnaire that included questions on both
coffee consumption by brewing method (filtered, instant,
boiled) and lifetime incidence of sunburn. We excluded
women with prevalent cancer other than non-melanoma
skin cancer, those who emigrated or died before the start
of follow-up (N = 3934), and those who did not have in-
formation on all three brewing methods (N = 2534). Fol-
lowing these exclusions, our final study sample consisted
of 104,080 women. Of these, 91,707 returned a follow-
up questionnaire 6–8 years after baseline, from which
updated information on coffee consumption was taken.
The remaining women (N = 12,373) that were recruited
in 2004, did not have follow-up information available, as
the follow-up questionnaire was sent out to them after
the present study ended.
Assessment of coffee consumption and sunburns
Both baseline and follow-up questionnaires contained
the same question on coffee consumption: How many
cups of coffee did you usually drink of each type (fil-
tered, instant, boiled) during the past year? However, the
response options for this question were different in the
two versions of the questionnaire that were used during
the study period. In the first version of the question-
naire, the women could choose between: never/seldom,
1–6 cups/week, 1 cup/day, 2–3 cups/day, 4–5 cups/day,
6–7 cups/day, and ≥8 cups/day. In the second version
they could choose between: never/seldom, 1–3 cups/month,
1 cup/week, 2–4 cups/week, 5–6 cups/week, 1 cup/day,
2–3 cups/day, 4–5 cups/day, and 6–10 cups/day. More-
over, 7467 women received a modified version of the
questionnaire at follow-up, in which they were asked to
report total coffee consumption only. Total coffee con-
sumption was calculated as the combined consumption
of all brewing methods, and women were categorized
by total coffee consumption, and by consumption of
filtered, instant, and boiled coffee as: light consumers
(≤1 cup/day), low-moderate consumers (>1–3 cups/day),
high moderate consumers (>3–5 cups/day), and heavy
consumers (>5 cups/day). As the size of a cup was not
specified in the questionnaire, we used 2.1 dl as a standard
cup size [15].
Information on the number of sunburns women sus-
tained during their lifetime was taken from the baseline
questionnaire, which collected information on the num-
ber of sunburns for 10-, 15-, 25- or 30-year periods, or a
combination of these, depending on the participants’ age
when the questionnaire was completed and the version
of the questionnaire. For those who reported sunburns
in at least three time periods, we calculated the average
number of sunburns per year. For participants that re-
ported sunburns in two time periods or less, the average
number of sunburns was set as missing.
Cancer incidence, death, and emigration
The unique 11-digit personal identification number
assigned to every legal resident in Norway was used
to acquire information on cancer incidence, death,
and emigration in the cohort through linkage to the
Norwegian Cancer Registry, the Cause of Death
Registry, and the Norwegian Central Population
Register, respectively. Cancer diagnoses were coded
according to the 7th Revision of the International
Classification of Diseases, Injuries and Causes of
Death. Code 190 was used to identify cases of malig-
nant melanoma.
Statistical methods
We used baseline information on coffee consumption
until follow-up information became available, until date
of diagnosis of any incident cancer other than non-
melanoma skin cancer, death, or emigration, whichever
occurred first. Once follow-up information became avail-
able, it was applied if the person remained in the study
until diagnosis of any incident cancer other than non-
melanoma skin cancer, death, emigration, or the end of
the study period (31 December 2013), whichever occurred
first [16]. We used Cox proportional hazards regression
models to calculate hazard ratios (HRs) for developing
malignant melanoma, with 95 % CIs, for each coffee con-
sumption category. Light consumers (≤1 cup/day) were
used as the reference group, as it was impossible to
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separate coffee abstainers and occasional coffee drinkers
from the answers offered in the questionnaires. Attained
age was used as the underlying time scale. All the models
were stratified by questionnaire subcohort (i.e., recruit-
ment in 1991–1992, 1996–1997, or 2003–2004) in order
to control for potential differences in the long follow-up
time.
We assessed the following potential confounders: aver-
age number of sunburns per year, original hair color,
number of moles larger than 5 mm, and area of resi-
dence [17, 18]. We also assessed lifestyle factors that
might confound the effect of coffee consumption on ma-
lignant melanoma: smoking status, education, body mass
index (BMI), physical activity level, and alcohol con-
sumption (g/day) [19–21]. The preliminary complete-
case analysis included baseline information on total cof-
fee consumption and potential confounders. As removal
of any of these covariates led to a change in the regres-
sion coefficients of 10 % or more in each of the total
coffee consumption categories, all of the potential con-
founders were retained as covariates in the final analyses
of total coffee consumption and in brewing method-
specific analyses. In addition, brewing method-specific
analyses were adjusted for the two other brewing
methods.
Due to the low number of cases in the highest con-
sumption categories of boiled and instant coffee, we de-
cided to conduct an additional analysis on the brewing
methods. In the analysis, we dichotomized coffee con-
sumption into “≤3 cups/month” (reference group), and
“≥1 cup/week”.
We assessed linear trends by assigning a median value
to each category of the ordinal coffee consumption vari-
able, which was then modeled as a continuous variable
in the analysis. We checked the proportional hazards as-
sumption by visual inspection of the log-minus-log sur-
vival plot. Finally, we tested possible effect modification
between coffee consumption and smoking status, BMI
and average number of sunburns per year.
Multiple imputation
In order to deal with missing information at baseline
and follow-up, we performed multiple imputation under
the assumption that data were missing at random. The
missing values from baseline and follow-up were re-
placed by imputed values from 20 duplicate datasets that
were created in order to reduce sampling variability
from the imputation simulation [22].
All covariates used in the multivariable analyses were
used as predictors in the imputation model. In addition,
we used the Nelson-Aalen cumulative hazard estimator
as a predictor along with the participants’ age at baseline
in the imputation model [23]. Interaction terms between
coffee consumption and smoking status or average
number of sunburns were included as predictors in the
imputation model if they were statistically significant in
the complete-case analysis.
If total coffee consumption at follow-up was missing
this value was not imputed, but calculated as the sum of
the imputed values on consumption of filtered, instant,
and boiled coffee. We imputed coffee consumption for
the three brewing methods at follow-up for the 7467
women who received the version of the questionnaire
that asked about total coffee consumption only.
The estimates from the twenty imputed datasets were
combined using Rubin’s rules in order to obtain HRs
and corresponding 95 % CIs [24]. All the analyses and
the multiple imputations were done in STATA version
14.0 (Stata Corp, College Station, TX, USA).
Results
During 1.7 million person-years of follow-up, there were
762 malignant melanoma cases. Mean follow-up time
was 16.3 years. During follow-up there was an overall
decrease in coffee consumption, mainly due to a drop in
boiled and filtered coffee consumption (Table 1). The
numbers of malignant melanoma cases across coffee
consumption categories at the baseline are presented in
Table 2.
The proportion of current smokers was lowest among
light consumers and increased with higher coffee con-
sumption, with 56.3 % of women drinking 5 or more
cups of coffee/day being current smokers. There was a
negative trend between total coffee consumption and
duration of education, with an average of 13.1 years of
schooling among light consumers and 11.1 years among
heavy consumers. The average lifetime number of sun-
burns was similar across categories of total coffee con-
sumption. Heavy consumers resided mainly in the
northern and eastern part of the country (Table 3).
The variables with the highest proportion of missing
values at baseline were average numbers of sunburns
(10.7 %), number of moles larger than 5 mm (10.0 %),
and physical activity level (9.2 %). At follow-up, 22.9 %
had missing values on total coffee consumption and
30.5 % had missing information on each brewing
method. After multiple imputation, the characteristics of
the study sample did not deviate substantially from the
complete-case dataset (Table 4).
Compared to light consumers of filtered coffee, we
found a statistically significant inverse association be-
tween low moderate (HR = 0.80; 95 % CI 0.66–0.98) and
high moderate (HR = 0.77; 95 % CI 0.61–0.97) consump-
tion of filtered coffee and the risk of malignant melan-
oma (ptrend = 0.02). There was a borderline, non-
significant association between heavy consumption of fil-
tered coffee and the risk of malignant melanoma (HR =
0.74; 95 % CI 0.53–1.02). We found no association
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between heavy consumption of boiled coffee (>5 vs
≤1 cup/day HR = 0.87; 95 % CI 0.49–1.55), instant coffee
(>5 vs ≤1 cup/day HR = 1.45; 95 % CI 0.72–2.92), or heavy
total coffee consumption (>5 vs ≤1 cup/day HR = 0.88;
95 % CI 0.67–1.14) and the risk of malignant melanoma.
Similarly, no association was found when comparing the
low-moderate and high-moderate consumption categories
of total, instant, or boiled coffee with light consumption
(Table 5). The risk estimates without adjustment for
phenotypic and sun related factors are presented in the
Additional file 1: Table S1.
We did not find evidence of effect modification be-
tween coffee consumption and smoking status, BMI or
average number of sunburns. After excluding melanoma
cases diagnosed during the first year of follow-up and re-
peating the analyses for each of the brewing methods,
the risk estimates were similar to those from the ana-
lyses that included the entire study sample (data not
shown).
The analysis in which coffee consumption was dichot-
omized into “≤3 cups/month” and “≥1 cup/week” cat-
egories confirmed null findings from the main analysis
regarding the association between instant and boiled cof-
fee consumption and melanoma risk (Additional file 1:
Table S2).
We conducted sensitivity analyses on different brewing
methods for the 7467 women who received a version of
the questionnaire that collected only information on
Table 1 Distribution of participants according to total, filtered, instant, and boiled coffee consumption, the Norwegian Women and
Cancer Study, 1991–2013 - complete case analyses
Total coffee consumption
Light consumers Low moderate consumers High moderate consumers Heavy consumers
≤1 cup/day >1–3 cups/day >3–5 cups/day >5 cups/day
Baseline, N (%) 16,853 (16.2) 29,923 (28.7) 34,451 (33.1) 22,853 (22.0)
Follow-up, N (%) 13,712 (19.4) 25,113 (35.5) 21,154 (29.9) 10,717 (15.2)
Filtered coffee consumption
≤1 cup/day >1–3 cups/day >3–5 cups/day >5 cups/day
Baseline, N (%) 41,942 (40.3) 26,708 (25.7) 23,014 (22.1) 12,416 (11.9)
Follow-up, N (%) 24,450 (38.3) 19,868 (31.2) 13,257 (20.8) 6179 (9.7)
Instant coffee consumption
≤1 cup/day >1–3 cups/day >3–5 cups/day >5 cups/day
Baseline, N (%) 95,584 (91.8) 5563 (5.3) 2070 (2.0) 863 (0.8)
Follow-up, N (%) 58,108 (91.1) 3941 (6.2) 1212 (1.9) 493 (0.8)
Boiled coffee consumption
≤1 cup/day >1–3 cups/day >3–5 cups/day >5 cups/day
Baseline, N (%) 83,094 (79.8) 8283 (8.0) 7474 (7.8) 5229 (5.0)
Follow-up, N (%) 56,441 (88.5) 3671 (5.8) 2258 (3.5) 1384 (2.2)
Table 2 Distribution of malignant melanoma cases according to total, filtered, instant, and boiled coffee consumption at baseline,
the Norwegian Women and Cancer Study, 1991–2013
Total coffee consumption Filtered coffee consumption Instant coffee consumption Boiled coffee consumption
n (%) n (%) n (%) n (%)
Light consumers 134 (17.6) 305 (40.0) 627 (82.3) 691 (90.7)
≤1 cup/day
Low-moderate consumers 234 (30.7) 218 (28.6) 57 (7.5) 45 (5.9)
>1–3 cups/day
High-moderate consumers 239 (31.4) 160 (21.0) 51 (6.7) 16 (1.3)
>3–5 cups/day
Heavy consumers 155 (20.3) 79 (10.4) 27 (3.5) 10 (2.1)
>5 cups/day
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total coffee consumption at follow-up. In these ana-
lyses, the baseline values were used throughout the
study period. The effect estimates did not change com-
pared to those obtained using imputed values (data not
shown).
Discussion
In this study, we added to the current knowledge on the
effects of coffee consumption on the risk of malignant
melanoma by including different coffee brewing methods
(filtered, instant, and boiled). We found that a low
moderate (>1–3 cups/day) or high moderate (>3–5
cups/day) intake of filtered coffee was associated with a
decreased risk of malignant melanoma, accompanied
with a statistically significant dose–response relation-
ship. There was no association between instant, boiled,
or total coffee consumption and melanoma risk.
Strengths of this study include the prospective design
and a large sample size. Linkage to the Norwegian Can-
cer Registry allowed us to perform virtually complete
follow-up of cancer cases. The external validation study
indicates that the responders do not differ from the
Table 3 Selected characteristics of the study sample by total coffee consumption at baseline, the Norwegian Women and Cancer
Study, 1996–2013 - complete case analyses
Characteristics Total coffee consumption
Light consumers Low-moderate consumers High-moderate consumers Heavy consumers
≤1 cup/day >1–3 cups/day >3–5 cups/day >5 cups/day
Age at baseline (y), mean (SD) 47.8 (8.6) 49.0 (8.7) 47.4 (8.2) 46.3 (7.8)
Age at study exit (y), mean (SD) 63.4 (6.8) 64.6 (7.3) 64.1 (6.9) 63.5 (6.5)
Smoking status, %
Never 50.8 42.4 31.6 17.1
Former 31.5 35.9 33.2 26.6
Current 17.7 21.7 35.2 56.3
Duration of education (y), mean (SD) 13.1 (3.6) 12.5 (3.5) 11.9 (3.3) 11.1 (3.1)
Body mass index, mean (SD) 24.0 (4.2) 24.0 (3.8) 23.9 (3.7) 24.0 (3.9)
Physical activity level, mean (SD) 5.5 (1.9) 5.7 (1.8) 5.7 (1.9) 5.5 (2.0)
Alcohol consumption (g/day), mean (SD) 3.0 (5.5) 3.4 (4.9) 3.3 (4.6) 3.2 (6.9)
Average number of sunburns per year, mean (SD) 0.9 (0.7) 0.8 (0.7) 0.8 (0.7) 0.8 (0.7)
Original hair color, %
Dark 17.7 17.1 17.1 17.6
Brown 38.9 39.6 40.0 40.0
Blond 40.5 40.2 40.0 39.4
Ginger 2.9 3.1 2.8 3.0
Number of moles larger than 5 mm, %
0 88.3 88.7 88.6 88.8
1 6.9 6.5 6.7 6.6
2–3 3.3 3.3 3.3 3.0
4–6 0.9 0.8 0.9 0.9
7–12 0.3 0.3 0.3 0.5
13–24 0.1 0.1 0.2 0.1
≥25 0.1 0.1 0.1 0.1
Area of residence, %
Oslo area 14.7 10.2 7.2 5.3
Eastern Norway 39.9 36.2 34.8 30.7
Southern Norway 5.0 4.6 4.7 4.7
Western Norway 20.1 23.2 22.3 19.3
Middle Norway 6.7 7.7 8.2 9.0
Northern Norway 13.7 18.1 22.8 30.9
y years, SD standard deviation
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source population other than in somewhat higher educa-
tional level. The observed cumulated incidence rates for
all cancer sites in the NOWAC study were almost iden-
tical to national figures [14, 25]. A 24-h dietary recall
validation of the food frequency questionnaires used has
shown a high validity of the information on coffee
consumption (Spearman’s correlation coefficient r =
0.82) [15]. We used repeated measurements of coffee
consumption in order to take into account changes in
coffee consumption over time, which lowered the risk of
measurement error. Finally, in order to maximize the
number of participants, person-years, and melanoma
Table 4 Comparison of the complete-case dataset and the dataset with imputed values (multiple imputation), the Norwegian
Women and Cancer Study, 1996–2013
Characteristics Missing, N(%) Complete-case Multiple imputation
Total coffee consumption-baseline, mean (SD) 0 (0.0) 3.9 (2.5) 3.9 (2.5)
Total coffee consumption-follow-up, mean (SD) 21,011 (22.9) 3.4 (2.2) 3.4 (2.2)
Filtered coffee consumption-baseline, mean (SD) 0 (0.0) 2.6 (2.4) 2.6 (2.4)
Filtered coffee consumption-follow-up, mean (SD) 27,953 (30.5) 2.5 (2.2) 2.5 (2.2)
Instant coffee consumption-baseline, mean (SD) 0 (0.0) 0.3 (1.1) 0.3 (1.1)
Instant coffee consumption-follow-up, mean (SD) 27,953 (30.5) 0.4 (1.0) 0.4 (1.0)
Boiled coffee consumption-baseline, mean (SD) 0 (0.0) 0.9 (2.0) 0.9 (2.0)
Boiled coffee consumption-follow-up, mean (SD) 27,953 (30.5) 0.5 (1.4) 0.5 (1.4)
Smoking status, %
Never 1595 (1.5) 34.6 34.7
Former 32.2 32.2
Current 33.1 33.1
Duration of education (y), mean (SD) 5184 (5.0) 12.1 (3.4) 12.0 (3.4)
Body mass index, mean (SD) 2379 (2.3) 24.0 (3.8) 24.0 (3.8)
Physical activity level, mean (SD) 9560 (9.2) 5.6 (1.9) 5.6 (1.9)
Alcohol consumption (g/day), mean (SD) 1686 (1.6) 3.2 (5.4) 3.2 (5.4)
Average number of sunburns per year, mean (SD) 11,103 (10.7) 0.8 (0.7) 0.8 (0.7)
Original hair color, %




Number of moles larger than 5 mm, %







Area of residence 0 (0.0)
Oslo area 8.9 8.9
Eastern Norway 35.1 35.1
Southern Norway 4.7 4.7
Western Norway 21.5 21.5
Middle Norway 8.0 8.0
Northern Norway 21.8 21.8
y years, SD standard deviation
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Table 5 Hazard ratios (HRs) with 95 % confidence intervals (CI) of malignant melanoma (n = 762) according to total, filtered, instant, and boiled coffee consumption in the
Norwegian Women and Cancer Study, 1991–2013 (N = 104,080)
Total coffee consumption Filtered coffee consumption Instant coffee consumption Boiled coffee consumption
Age-adjusted Multivariablea Age-adjusted Multivariableb Age-adjusted Multivariableb Age-adjusted Multivariableb
HR HR HR HR HR HR HR HR
95 % CI 95 % CI 95 % CI 95 % CI 95 % CI 95 % CI 95 % CI 95 % CI
Light consumers 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
≤1 cup/day
Low-moderate consumers 0.93 (0.76–1.14) 0.95 (0.78–1.16) 0.85 (0.71–1.02) 0.80 (0.66–0.98) 1.34 (1.01–1.77) 1.17 (0.88–1.57) 1.01 (0.74–1.39) 1.13 (0.81–1.58)
>1–3 cups/day
High-moderate consumers 0.77 (0.63–0.96) 0.85 (0.68–1.05) 0.77 (0.62–0.96) 0.77 (0.61–0.97) 0.92 (0.52–1.63) 0.85 (0.48–1.52) 0.74 (0.48–1.13) 0.89 (0.58–1.39)
>3–5 cups/day
Heavy consumers 0.72 (0.56–0.92) 0.88 (0.67–1.14) 0.68 (0.50–0.92) 0.74 (0.53–1.02) 1.56 (0.78–3.10) 1.45 (0.72–2.92) 0.66 (0.38–1.14) 0.87 (0.49–1.55)
>5 cups/day
ptrend 0.002 0.20 0.002 0.02 0.10 0.39 0.07 0.72
Cat. categorical, cont. continuous
aAdjusted for smoking status, duration of education (cat.), body mass index (cat.), physical activity level (cont.), alcohol consumption (g/day) (cat.), area of residence, original hair color, number of moles larger than
5 mm (cat.), average number of sunburns per year (cont.)
bAdjusted for smoking status, duration of education (cat.), body mass index (cat.), physical activity level (cont.), alcohol consumption (g/day) (cat.), area of residence, original hair color, number of moles larger than











cases included in the analyses, we used multiple imput-
ation to deal with missing data.
There are also several limitations in the study.
While we had sufficient statistical power to detect dif-
ferences between categories of total and filtered coffee
consumption, the analyses of instant and boiled coffee
were statistically underpowered. However, when we
combined coffee consumption categories in order to in-
crease the number of cases among the women who
drank these coffee types, findings were similar to those
from the main analysis. We decided to use women who
drank ≤1 cup of coffee/day rather than “never/seldom”
coffee consumers as the reference group, due to a low
number of cases among “never/seldom” total coffee con-
sumers. Moreover, seldom drinking or abstaining from
coffee is relatively uncommon in Norway. Therefore, we
believe that those women could differ from the women
who reported drinking coffee more frequently, making
them less appropriate as a reference group.
The information on certain types of coffee drinks, such
as macchiato, espresso, cappuccino, or café latte, was
not available from the questionnaires. Therefore, total
coffee consumption may have been underestimated.
However, consumption of such particular coffee drinks
was uncommon among the women in the cohort at the
time of data collection. Similarly, information on caffei-
nation status was not available from the questionnaires.
However, the consumption of decaffeinated coffee is un-
common in Norway. Hence, the measure of total coffee
consumption used in the analyses was likely not sub-
stantially different from the true overall coffee intake.
Tea consumption was not taken into account in the ana-
lyses, as this information was not available from all the
NOWAC questionnaires. Tea contains some of the same
anticarcinogenic components as coffee, and we cannot
exclude a confounding effect of tea consumption. Fi-
nally, although we adjusted for many known risk factors,
residual confounding cannot be completely ruled out.
Although a study confirmed the validity of the infor-
mation on coffee consumption in the NOWAC ques-
tionnaires, misclassification is still possible. By using
follow-up information on coffee consumption, we tried
to reduce within-person variation and minimize the risk
of misclassification bias. Nevertheless, misclassification
due to a measurement error at both baseline and follow-
up cannot be excluded, as information on coffee con-
sumption was self-reported. Lifetime number of sunburns
is a variable that cannot be validated. As such, retrospect-
ive reporting of sunburns over a period of decades may be
only a rough estimate of the truth.
Information on ethnicity is not available in the
NOWAC Study. If coffee drinking prevalence differed by
ethnicity in the cohort, this could have been an unmeas-
ured confounder. However, previous studies on sun
exposure and melanoma in the NOWAC cohort con-
cluded that hair color is a good indicator of sensitivity to
sun exposure [18, 26]. Moreover, the percentage of mi-
grants participating in the NOWAC study is likely very
low, given the very low prevalence of foreign born
women in the population at the time when the cohort
was enrolled, and the fact that the questionnaires were
all only available in Norwegian language.
We imputed missing information at baseline and
follow-up, assuming a missing-at-random mechanism.
All of the variables used in the main analyses were in-
cluded in the imputation model. However, it is possible
that at least some of the information was not missing at
random, which would result in the obtained estimates
not being completely free of bias. Finally, there were
7467 women who received a version of the questionnaire
that only collected information on total coffee consump-
tion at follow-up. For some of these women, the im-
puted values of the three brewing methods did not add
up to the total coffee consumption they reported. How-
ever, when we conducted the analyses using the baseline
values on different brewing methods for these women
throughout the study period instead of imputing, the ef-
fect estimates were not different from those obtained
using imputed values.
To our knowledge, this is the first study examining the
effect of filtered, instant, boiled and total coffee con-
sumption on the risk of malignant melanoma that used
repeated information on coffee intake and combined this
method with multiple imputation of missing data.
Evidence of no association between total, filtered, and
boiled coffee intake and melanoma risk were found in the
Swedish Västerbotten Intervention Project (VIP) involving
both men and women [27]. The study had considerably
fewer cases (n = 108), hence insufficient statistical power
in order to detect weak associations. In two smaller stud-
ies in Norwegian women, both Stensvold and Jacobsen
[28], and Veierød et al. [10] found a strong inverse associ-
ation between heavy coffee consumption (≥7 cups/day)
and melanoma risk (relative risk = 0.3, 48 cases; incidence
rate ratio = 0.4, 61 cases, respectively). These studies,
however, used “≤2 cups/day” as the reference group, in
addition to a less extensive sun exposure adjustment. Fur-
thermore, no information of brewing methods were pre-
sented in either of the studies. If filtered coffee was the
most common brewing method among the participants,
the results from these studies would reflect our findings.
A protective effect of caffeinated coffee consumption
on melanoma risk was also found in the considerably
larger National Institutes of Health-AARP Diet and
Health (NIH-AARP) prospective cohort study (≥4 cups/
day vs none HR = 0.80; 95 % CI 0.69–0.93). Despite not
presenting results by gender, the authors reported that
there was no significant heterogeneity in the results
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between men and women [8]. In the US, filtered coffee
is predominant compared to other brewing methods
[29], so it can be argued that the results from the NIH-
AARP study are in line with our results. Similar findings
were reported in the Nurses’ Health Study and Nurses’
Health Study II, which utilized updated information on
coffee consumption throughout the follow-up period,
and reported a 24 % risk reduction in women who drank
>2 cups of coffee/day compared to non-coffee drinkers
(95 % CI 0.64–0.89) [9]. Their risk estimates were similar
to the estimates of filtered coffee consumption in the
present study, despite the differences in the way of
handling missing data at follow-up between these stud-
ies. In contrast, coffee consumption was not associated
with risk of melanoma in the Women’s Health Initiative
– Observational Study cohort of 66,484 postmenopausal
women [7]. Finally, in a recent meta-analysis of two
case–control and five cohort studies, Liu et al. reported
a pooled relative risk of malignant melanoma of 0.81
(95 % CI 0.68–0.97) comparing the highest and the low-
est quantity of caffeinated coffee intake [30].
Most experimental research on coffee constituents and
skin cancer has been done on non-melanoma skin can-
cer, and there is clearly a need for mechanistic studies
on the possible causal link between coffee and malignant
melanoma. Caffeine, chlorogenic acid, cafestol, kahweol,
and melanoidins are the most researched coffee constit-
uents in relation to health [4], and have shown a range
of anticarcinogenic effects in lab studies [4, 31]. We
found an inverse association with filtered coffee, which
rules out cafestol and kahweol as antimelanogenic com-
pounds, since the content of diterpenes in filtered coffee
is very low [5].
In UVB-induced non-melanoma skin cancer in mice,
topical administration of caffeine induces an apoptotic
response [32], and oral administration of caffeine in-
hibits the increase of cytokines responsible for the UVB-
induced inflammatory response, which is thought to
contribute to carcinogenesis, an effect similar to, and
more effective when combined with, voluntary exercise
[33]. The effect could be due to the positive effects of
decreased body fat, or the fact that reduced subcutane-
ous fat restricts the energy available to skin tumors [34].
In a four-week intervention study in humans, filtered
coffee consumption decreased body fat [35] and chloro-
genic acid-enriched coffee decreased the expression of
the inflammation marker interleukin 6 (IL6) [36]. We
did not observe a difference in BMI or physical activity
across categories of total coffee consumption.
The hallmarks of melanogenesis have been defined
[37], and coffee contains compounds that target all of
these hallmarks [31]. However, there seems to be little
overlap in the pathways. Expansion of this multitarget
functional perspective on coffee would be interesting.
Little is known about the bioavailability of coffee compo-
nents and coffee metabolites in human blood, and the
physiological function of antioxidants and chemopreven-
tive compounds in the diet [4], and this could be in-
cluded in further studies using questionnaire data and
blood samples.
Conclusion
In the NOWAC Study, moderate consumption of fil-
tered coffee is associated with a decreased risk of malig-
nant melanoma. We found no evidence of an association
between instant, boiled, or total coffee consumption and
the risk of malignant melanoma.
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